Serum Lipids and Lipoproteins in Chinese Men and Women

Because of rapid change in lifestyle risk factors, cardiovascular disease has become the leading cause of death in China. We sought to estimate the national levels of serum lipids and lipoproteins among the Chinese adult population. We conducted a cross-sectional study in a nationally representative...

Full description

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 125; no. 18; pp. 2212 - 2221
Main Authors Yang, Wenying, Xiao, Jianzhong, Yang, Zhaojun, Ji, Linong, Jia, Weiping, Weng, Jianping, Lu, Juming, Shan, Zhongyan, Liu, Jie, Tian, Haoming, Ji, Qiuhe, Zhu, Dalong, Ge, Jiapu, Lin, Lixiang, Chen, Li, Guo, Xiaohui, Zhao, Zhigang, Li, Qiang, Zhou, Zhiguang, Shan, Guangliang, He, Jiang
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 08.05.2012
Subjects
Online AccessGet full text
ISSN0009-7322
1524-4539
1524-4539
DOI10.1161/CIRCULATIONAHA.111.065904

Cover

Abstract Because of rapid change in lifestyle risk factors, cardiovascular disease has become the leading cause of death in China. We sought to estimate the national levels of serum lipids and lipoproteins among the Chinese adult population. We conducted a cross-sectional study in a nationally representative sample of 46 239 adults aged ≥20 years. Fasting serum total, high-density lipoprotein, and low-density lipoprotein cholesterol and triglycerides were measured by standard methods. The age-standardized estimates of total, high-density lipoprotein, and low-density lipoprotein cholesterol and triglycerides were 4.72 (95% confidence interval, 4.70-4.73), 1.30 (1.29-1.30), 2.68 (2.67-2.70), and 1.57 (1.55-1.58) mmol/L, respectively, in the Chinese adult population. In addition, 22.5% (21.8-23.3%) or 220.4 million (212.1-228.8) Chinese adults had borderline high total cholesterol (5.18-6.21 mmol/L), and 9.0% (8.5-9.5%) or 88.1 million (83.4-92.8) had high total cholesterol (≥6.22 mmol/L). The population estimates for borderline high (3.37-4.13 mmol/L), high (4.14-4.91 mmol/L), and very high (≥4.92 mmol/L) low-density lipoprotein cholesterol were 13.9% (13.3-14.5%) or 133.5 million (127.0-140.1), 3.5% (3.3-3.8%) or 33.8 million (31.2-36.5), and 3.0% (2.8-3.3%) or 29.0 million (26.3-31.8) persons, respectively. In addition, 22.3% (21.6-23.1%) or 214.9 million (207.0-222.8) persons had low high-density lipoprotein cholesterol (<1.04 mmol/L). The awareness, treatment, and control of borderline high or high total cholesterol were 11.0%, 5.1%, and 2.8%, respectively, in the Chinese adult population. Serum total and low-density lipoprotein cholesterol levels were high and increasing in the Chinese population. Without effective intervention, atherosclerotic cardiovascular diseases may soar in the near future in China.
AbstractList Because of rapid change in lifestyle risk factors, cardiovascular disease has become the leading cause of death in China. We sought to estimate the national levels of serum lipids and lipoproteins among the Chinese adult population.BACKGROUNDBecause of rapid change in lifestyle risk factors, cardiovascular disease has become the leading cause of death in China. We sought to estimate the national levels of serum lipids and lipoproteins among the Chinese adult population.We conducted a cross-sectional study in a nationally representative sample of 46 239 adults aged ≥20 years. Fasting serum total, high-density lipoprotein, and low-density lipoprotein cholesterol and triglycerides were measured by standard methods. The age-standardized estimates of total, high-density lipoprotein, and low-density lipoprotein cholesterol and triglycerides were 4.72 (95% confidence interval, 4.70-4.73), 1.30 (1.29-1.30), 2.68 (2.67-2.70), and 1.57 (1.55-1.58) mmol/L, respectively, in the Chinese adult population. In addition, 22.5% (21.8-23.3%) or 220.4 million (212.1-228.8) Chinese adults had borderline high total cholesterol (5.18-6.21 mmol/L), and 9.0% (8.5-9.5%) or 88.1 million (83.4-92.8) had high total cholesterol (≥6.22 mmol/L). The population estimates for borderline high (3.37-4.13 mmol/L), high (4.14-4.91 mmol/L), and very high (≥4.92 mmol/L) low-density lipoprotein cholesterol were 13.9% (13.3-14.5%) or 133.5 million (127.0-140.1), 3.5% (3.3-3.8%) or 33.8 million (31.2-36.5), and 3.0% (2.8-3.3%) or 29.0 million (26.3-31.8) persons, respectively. In addition, 22.3% (21.6-23.1%) or 214.9 million (207.0-222.8) persons had low high-density lipoprotein cholesterol (<1.04 mmol/L). The awareness, treatment, and control of borderline high or high total cholesterol were 11.0%, 5.1%, and 2.8%, respectively, in the Chinese adult population.METHODS AND RESULTSWe conducted a cross-sectional study in a nationally representative sample of 46 239 adults aged ≥20 years. Fasting serum total, high-density lipoprotein, and low-density lipoprotein cholesterol and triglycerides were measured by standard methods. The age-standardized estimates of total, high-density lipoprotein, and low-density lipoprotein cholesterol and triglycerides were 4.72 (95% confidence interval, 4.70-4.73), 1.30 (1.29-1.30), 2.68 (2.67-2.70), and 1.57 (1.55-1.58) mmol/L, respectively, in the Chinese adult population. In addition, 22.5% (21.8-23.3%) or 220.4 million (212.1-228.8) Chinese adults had borderline high total cholesterol (5.18-6.21 mmol/L), and 9.0% (8.5-9.5%) or 88.1 million (83.4-92.8) had high total cholesterol (≥6.22 mmol/L). The population estimates for borderline high (3.37-4.13 mmol/L), high (4.14-4.91 mmol/L), and very high (≥4.92 mmol/L) low-density lipoprotein cholesterol were 13.9% (13.3-14.5%) or 133.5 million (127.0-140.1), 3.5% (3.3-3.8%) or 33.8 million (31.2-36.5), and 3.0% (2.8-3.3%) or 29.0 million (26.3-31.8) persons, respectively. In addition, 22.3% (21.6-23.1%) or 214.9 million (207.0-222.8) persons had low high-density lipoprotein cholesterol (<1.04 mmol/L). The awareness, treatment, and control of borderline high or high total cholesterol were 11.0%, 5.1%, and 2.8%, respectively, in the Chinese adult population.Serum total and low-density lipoprotein cholesterol levels were high and increasing in the Chinese population. Without effective intervention, atherosclerotic cardiovascular diseases may soar in the near future in China.CONCLUSIONSSerum total and low-density lipoprotein cholesterol levels were high and increasing in the Chinese population. Without effective intervention, atherosclerotic cardiovascular diseases may soar in the near future in China.
Because of rapid change in lifestyle risk factors, cardiovascular disease has become the leading cause of death in China. We sought to estimate the national levels of serum lipids and lipoproteins among the Chinese adult population. We conducted a cross-sectional study in a nationally representative sample of 46 239 adults aged ≥20 years. Fasting serum total, high-density lipoprotein, and low-density lipoprotein cholesterol and triglycerides were measured by standard methods. The age-standardized estimates of total, high-density lipoprotein, and low-density lipoprotein cholesterol and triglycerides were 4.72 (95% confidence interval, 4.70-4.73), 1.30 (1.29-1.30), 2.68 (2.67-2.70), and 1.57 (1.55-1.58) mmol/L, respectively, in the Chinese adult population. In addition, 22.5% (21.8-23.3%) or 220.4 million (212.1-228.8) Chinese adults had borderline high total cholesterol (5.18-6.21 mmol/L), and 9.0% (8.5-9.5%) or 88.1 million (83.4-92.8) had high total cholesterol (≥6.22 mmol/L). The population estimates for borderline high (3.37-4.13 mmol/L), high (4.14-4.91 mmol/L), and very high (≥4.92 mmol/L) low-density lipoprotein cholesterol were 13.9% (13.3-14.5%) or 133.5 million (127.0-140.1), 3.5% (3.3-3.8%) or 33.8 million (31.2-36.5), and 3.0% (2.8-3.3%) or 29.0 million (26.3-31.8) persons, respectively. In addition, 22.3% (21.6-23.1%) or 214.9 million (207.0-222.8) persons had low high-density lipoprotein cholesterol (<1.04 mmol/L). The awareness, treatment, and control of borderline high or high total cholesterol were 11.0%, 5.1%, and 2.8%, respectively, in the Chinese adult population. Serum total and low-density lipoprotein cholesterol levels were high and increasing in the Chinese population. Without effective intervention, atherosclerotic cardiovascular diseases may soar in the near future in China.
Author Jia, Weiping
Yang, Wenying
Lu, Juming
Tian, Haoming
Zhu, Dalong
Shan, Guangliang
Chen, Li
He, Jiang
Guo, Xiaohui
Liu, Jie
Ji, Qiuhe
Xiao, Jianzhong
Li, Qiang
Lin, Lixiang
Ge, Jiapu
Zhou, Zhiguang
Yang, Zhaojun
Ji, Linong
Zhao, Zhigang
Weng, Jianping
Shan, Zhongyan
Author_xml – sequence: 1
  givenname: Wenying
  surname: Yang
  fullname: Yang, Wenying
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 2
  givenname: Jianzhong
  surname: Xiao
  fullname: Xiao, Jianzhong
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 3
  givenname: Zhaojun
  surname: Yang
  fullname: Yang, Zhaojun
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 4
  givenname: Linong
  surname: Ji
  fullname: Ji, Linong
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 5
  givenname: Weiping
  surname: Jia
  fullname: Jia, Weiping
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 6
  givenname: Jianping
  surname: Weng
  fullname: Weng, Jianping
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 7
  givenname: Juming
  surname: Lu
  fullname: Lu, Juming
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 8
  givenname: Zhongyan
  surname: Shan
  fullname: Shan, Zhongyan
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 9
  givenname: Jie
  surname: Liu
  fullname: Liu, Jie
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 10
  givenname: Haoming
  surname: Tian
  fullname: Tian, Haoming
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 11
  givenname: Qiuhe
  surname: Ji
  fullname: Ji, Qiuhe
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 12
  givenname: Dalong
  surname: Zhu
  fullname: Zhu, Dalong
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 13
  givenname: Jiapu
  surname: Ge
  fullname: Ge, Jiapu
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 14
  givenname: Lixiang
  surname: Lin
  fullname: Lin, Lixiang
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 15
  givenname: Li
  surname: Chen
  fullname: Chen, Li
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 16
  givenname: Xiaohui
  surname: Guo
  fullname: Guo, Xiaohui
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 17
  givenname: Zhigang
  surname: Zhao
  fullname: Zhao, Zhigang
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 18
  givenname: Qiang
  surname: Li
  fullname: Li, Qiang
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 19
  givenname: Zhiguang
  surname: Zhou
  fullname: Zhou, Zhiguang
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 20
  givenname: Guangliang
  surname: Shan
  fullname: Shan, Guangliang
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
– sequence: 21
  givenname: Jiang
  surname: He
  fullname: He, Jiang
  organization: From the China-Japan Friendship Hospital, Beijing, China (W.Y., J.X., Z.Y.); Peking University Peoples' Hospital, Beijing, China (L.J.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China (W.J.); Sun Yat-sen University Third Hospital, Guangzhou, China (J.W.); Chinese PLA General Hospital, Beijing, China (J. Lu); First Affiliated Hospital, Chinese Medical University, Liaoling, China (Z.S.); Shanxi Province People's Hospital, Shanxi, China (J. Liu); West China Hospital
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25884768$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22492668$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtPxCAUhYkZ4zz0L5i6MHHTESjQsjJNo84ko5PoTFw2lNKIaekI7cJ_L_OK0Y2ry7334xzIGYOBaY0C4ArBKUIM3Wbzl2y9SFfz5XM6S_0MTSGjHJITMEIUk5DQiA_ACELIwzjCeAjGzn34lkUxPQNDjAnHjCUjwF6V7ZtgoTe6dIEw5fbYbmzbKW1coE2QvWujnAqelNnt39pGmXNwWonaqYtDnYD1w_0qm4WL5eM8SxehJIx0IZIUs5jAgipRMRQVZRUxUfilTEpOKwyrBCW0wBSXjJYVgpxKVXIJaUIoRNEE3Ox1_Ys-e-W6vNFOqroWRrW9yxHECGEKMffo5QHti0aV-cbqRtiv_PhXD1wfAOGkqCsrjNTuh6NJQuIdd7fnpG2ds6rKpe5Ep1vTWaFr75lvU8h_p-BnKN-n4BX4H4Wjyf93vwG0q4sz
CODEN CIRCAZ
CitedBy_id crossref_primary_10_1155_2021_6264414
crossref_primary_10_3390_metabo13080947
crossref_primary_10_1093_eurheartj_ehab418
crossref_primary_10_1016_j_jacl_2018_06_011
crossref_primary_10_3390_toxins15040293
crossref_primary_10_1186_s12872_023_03399_1
crossref_primary_10_3390_ijerph16142555
crossref_primary_10_1016_j_atherosclerosis_2014_05_916
crossref_primary_10_1016_j_socscimed_2017_09_032
crossref_primary_10_1017_S000711451700157X
crossref_primary_10_1002_clc_23040
crossref_primary_10_1155_2014_709756
crossref_primary_10_1002_clc_23154
crossref_primary_10_4103_jfmpc_jfmpc_406_19
crossref_primary_10_1097_MD_0000000000014159
crossref_primary_10_1007_s12011_017_1213_x
crossref_primary_10_1038_s41598_018_24230_4
crossref_primary_10_1038_s41598_021_96864_w
crossref_primary_10_1097_MD_0000000000002677
crossref_primary_10_1371_journal_pone_0112715
crossref_primary_10_1186_s12944_019_0987_6
crossref_primary_10_1038_s41598_020_72780_3
crossref_primary_10_1038_s41598_022_18988_x
crossref_primary_10_1097_MD_0000000000008555
crossref_primary_10_1186_s12944_018_0802_9
crossref_primary_10_2217_clp_15_27
crossref_primary_10_1016_j_envres_2021_111174
crossref_primary_10_1186_s12933_018_0736_6
crossref_primary_10_1016_j_artere_2020_11_002
crossref_primary_10_1093_pubmed_fdz113
crossref_primary_10_1097_MOL_0000000000000580
crossref_primary_10_1016_j_arteri_2020_06_006
crossref_primary_10_1038_s41422_018_0123_6
crossref_primary_10_3389_fpubh_2022_868059
crossref_primary_10_3389_fendo_2024_1500712
crossref_primary_10_1016_j_jacl_2019_10_015
crossref_primary_10_1007_s11427_023_2523_5
crossref_primary_10_1016_j_biosystems_2016_05_001
crossref_primary_10_1186_s12889_024_20461_5
crossref_primary_10_1155_2020_9157430
crossref_primary_10_1186_1471_230X_13_110
crossref_primary_10_1371_journal_pone_0078270
crossref_primary_10_1177_2047487319843077
crossref_primary_10_1186_s41043_016_0067_8
crossref_primary_10_2217_clp_13_82
crossref_primary_10_1111_jebm_12291
crossref_primary_10_1161_JAHA_119_013479
crossref_primary_10_1186_s12944_015_0073_7
crossref_primary_10_1016_j_ijcard_2014_01_023
crossref_primary_10_1097_CP9_0000000000000013
crossref_primary_10_1186_s12872_020_01698_5
crossref_primary_10_1093_aje_kwv294
crossref_primary_10_1080_00949655_2020_1839900
crossref_primary_10_1186_s12944_017_0453_2
crossref_primary_10_3343_alm_2018_38_5_431
crossref_primary_10_1016_j_numecd_2021_10_009
crossref_primary_10_1186_1471_2458_14_961
crossref_primary_10_1186_s12944_020_01340_5
crossref_primary_10_3389_fendo_2023_1137098
crossref_primary_10_2147_CIA_S295252
crossref_primary_10_26599_1671_5411_2024_02_008
crossref_primary_10_51620_0869_2084_2021_66_12_728_732
crossref_primary_10_1097_FJC_0000000000000914
crossref_primary_10_1186_s12944_017_0548_9
crossref_primary_10_1186_s12944_016_0212_9
crossref_primary_10_1089_met_2019_0043
crossref_primary_10_1007_s11739_015_1305_6
crossref_primary_10_1093_ije_dyz099
crossref_primary_10_1093_eurheartj_suw030
crossref_primary_10_21320_1818_474X_2021_1_7_18
crossref_primary_10_1371_journal_pone_0268984
crossref_primary_10_1016_j_diabres_2024_111867
crossref_primary_10_1016_j_clinbiochem_2013_05_042
crossref_primary_10_3389_fneur_2020_00986
crossref_primary_10_1002_dmrr_2963
crossref_primary_10_1016_S2213_8587_15_00366_6
crossref_primary_10_1161_ATVBAHA_116_308456
crossref_primary_10_1001_jamanetworkopen_2023_5565
crossref_primary_10_1016_j_ijcard_2016_07_047
crossref_primary_10_1186_s12944_020_01313_8
crossref_primary_10_1002_fsn3_2492
crossref_primary_10_1016_j_ijheh_2024_114404
crossref_primary_10_1136_bmjopen_2021_054682
crossref_primary_10_1038_s41598_018_27248_w
crossref_primary_10_1080_00325481_2023_2263372
crossref_primary_10_3389_fphar_2023_1190934
crossref_primary_10_1016_j_pcd_2020_07_007
crossref_primary_10_1136_bmjopen_2021_052268
crossref_primary_10_1186_s12889_019_7212_4
crossref_primary_10_1093_lifemeta_loae032
crossref_primary_10_1186_s13063_016_1419_9
crossref_primary_10_26599_1671_5411_2023_09_008
crossref_primary_10_1016_j_atherosclerosis_2018_11_018
crossref_primary_10_1016_j_artere_2020_12_003
crossref_primary_10_1371_journal_pone_0135145
crossref_primary_10_1038_s41440_019_0281_z
crossref_primary_10_1186_s12933_024_02293_0
crossref_primary_10_1111_1346_8138_16299
crossref_primary_10_1016_j_arteri_2020_04_001
crossref_primary_10_1016_j_ijcard_2017_12_069
crossref_primary_10_1016_j_jff_2024_106033
crossref_primary_10_1371_journal_pone_0190310
crossref_primary_10_4103_0366_6999_191750
crossref_primary_10_1016_j_jacl_2016_01_009
crossref_primary_10_1016_j_jdiacomp_2015_09_016
crossref_primary_10_5551_jat_RV22013
crossref_primary_10_1016_j_lanwpc_2021_100096
crossref_primary_10_1016_j_jacl_2015_10_009
crossref_primary_10_1002_clc_23770
crossref_primary_10_1186_s12944_018_0923_1
crossref_primary_10_1371_journal_pone_0126832
crossref_primary_10_1097_MD_0000000000013048
crossref_primary_10_3390_biomedicines9121947
crossref_primary_10_1007_s40519_019_00803_8
crossref_primary_10_1016_j_atherosclerosis_2016_02_006
crossref_primary_10_1186_s12944_019_1000_0
crossref_primary_10_1161_CIRCULATIONAHA_115_008728
crossref_primary_10_1210_jc_2017_02789
crossref_primary_10_3390_nu14010050
crossref_primary_10_3390_ijerph13050516
crossref_primary_10_4239_wjd_v15_i2_240
crossref_primary_10_1111_dom_14450
crossref_primary_10_1016_j_jacc_2014_12_044
crossref_primary_10_1016_j_jacc_2016_06_011
crossref_primary_10_1161_CIRCULATIONAHA_116_022367
crossref_primary_10_1016_j_atherosclerosis_2013_12_003
crossref_primary_10_1016_j_toxrep_2020_11_011
crossref_primary_10_1186_s12944_020_01392_7
crossref_primary_10_1089_thy_2016_0010
crossref_primary_10_1371_journal_pone_0057319
crossref_primary_10_1038_srep34268
crossref_primary_10_1186_s12944_016_0328_y
crossref_primary_10_1038_s41598_021_95244_8
crossref_primary_10_1016_j_envpol_2025_126047
crossref_primary_10_1371_journal_pone_0178343
crossref_primary_10_1096_fj_201601022R
crossref_primary_10_2188_jea_JE20140252
crossref_primary_10_1089_thy_2014_0219
crossref_primary_10_1007_s11250_014_0535_3
crossref_primary_10_1038_s41598_023_42247_2
crossref_primary_10_1186_s12944_018_0768_7
crossref_primary_10_1080_07853890_2024_2409342
crossref_primary_10_1016_j_ihj_2014_03_005
crossref_primary_10_1186_s12931_019_1143_6
crossref_primary_10_3389_fimmu_2022_937201
crossref_primary_10_1038_srep22210
crossref_primary_10_2147_IJGM_S483324
Cites_doi 10.1093/ije/18.3_Supplement_1.S159
10.1161/01.CIR.85.3.1083
10.1016/j.amjcard.2004.07.046
10.1161/01.CIR.0000066320.27195.B4
10.1136/bmj.303.6797.276
10.1001/jama.2009.1672
10.1161/01.CIR.0000136583.52681.0D
10.1093/ajcn/69.4.632
10.1046/j.1467-789X.2002.00071.x
10.1001/jama.284.3.311
10.1001/jama.285.19.2486
10.1111/j.1467-789X.2010.00819.x
10.1016/S0140-6736(10)62038-7
10.1161/01.CIR.102.2.179
10.1056/NEJMoa0908292
10.1016/S0140-6736(98)03454-0
10.1093/ije/30.suppl_1.S35
10.1161/01.CIR.97.10.946
10.1371/journal.pone.0017326
10.1111/j.1753-4887.2009.00160.x
10.1001/jama.294.14.1773
10.1056/NEJMsa050467
10.1161/circulationaha.109.192703
10.1001/jama.282.24.2340
10.1001/jama.289.1.76
ContentType Journal Article
Contributor Fu, Zuzhi
Tian, Haoming
Wang, Beibei
Lu, Li
Liu, Jie
Yi, Wan
Xiang, Kunsan
Zou, Dajing
Mu, Panwei
Shan, Zhongyan
Yang, Wenying
Chen, Fei
Lu, Juming
Han, Gang
Zeng, Longyi
Gu, Huilin
Shan, Guangliang
Ji, Qiuhe
Xie, Xiaohua
Ma, Xiaojing
Pan, Zhijian
Wang, Shuyu
Xu, Ning
Sun, Xiuqing
Chen, Jialun
Zhang, Xiuying
Zhang, Yaping
Xu, Xiaodong
Ran, Xingwu
Zhao, Jingxin
Lu, Hualin
Xiao, Jianzhong
Aireti, Maimaiti
Xing, Huifang
Hu, Yun
Ji, Linong
Wang, Jiani
Dong, Liguang
Zhu, Dalong
Zhou, Xianghai
Wang, Rong
Bu, Shi
Hu, Ling
Lin, Mingzhu
Pei, Jiong
Yang, Shuyu
Zhang, Baojing
Hou, Xuhong
Ruan, Danjie
Ren, Yan
Cao, Lisheng
Li, Hongliang
Teng, Xiaochun
Wang, Peng
Pan, Changyu
Dou, Jingtao
Lu, Huijuan
Zhao, Dong
Gao, Xilian
Luo, Yingying
Mu, Huijie
Shan, Ling
Chen, Chung-Shiuan
Shi, Liangfeng
Lin, Keyi
Han, Xueyao
Jiang, Fengwei
Wang, Sen
Tong, Guoyu
Sun, Yan
Jin, Nan
Yu, Qiuqiong
Xiao, Zhiyun
Hou, Yuying
Lin, Lixiang
Lai, Yaxin
Chen, Gang
Li, Zhong
Yang, Zhaojun
Li, Yufeng
Zhang, Xinquan
Jia, Weiping
Cheng, Jinluo
Li, Jing
Hu, Renming
Huang, Junbin
He, Jiang
Liu, Lei
Shen, Weizhen
Zhan
Contributor_xml – sequence: 1
  givenname: Guangliang
  surname: Shan
  fullname: Shan, Guangliang
– sequence: 2
  givenname: Wenying
  surname: Yang
  fullname: Yang, Wenying
– sequence: 3
  givenname: Jianzhong
  surname: Xiao
  fullname: Xiao, Jianzhong
– sequence: 4
  givenname: Zhaojun
  surname: Yang
  fullname: Yang, Zhaojun
– sequence: 5
  givenname: Jiang
  surname: He
  fullname: He, Jiang
– sequence: 6
  givenname: Chung-Shiuan
  surname: Chen
  fullname: Chen, Chung-Shiuan
– sequence: 7
  givenname: Kunsan
  surname: Xiang
  fullname: Xiang, Kunsan
– sequence: 8
  givenname: Jialun
  surname: Chen
  fullname: Chen, Jialun
– sequence: 9
  givenname: Changyu
  surname: Pan
  fullname: Pan, Changyu
– sequence: 10
  givenname: Zuzhi
  surname: Fu
  fullname: Fu, Zuzhi
– sequence: 11
  givenname: Danjie
  surname: Ruan
  fullname: Ruan, Danjie
– sequence: 12
  givenname: Yufeng
  surname: Li
  fullname: Li, Yufeng
– sequence: 13
  givenname: Shi
  surname: Bu
  fullname: Bu, Shi
– sequence: 14
  givenname: Hongliang
  surname: Li
  fullname: Li, Hongliang
– sequence: 15
  givenname: Peng
  surname: Wang
  fullname: Wang, Peng
– sequence: 16
  givenname: Xueli
  surname: Liu
  fullname: Liu, Xueli
– sequence: 17
  givenname: Zhiyun
  surname: Xiao
  fullname: Xiao, Zhiyun
– sequence: 18
  givenname: Juming
  surname: Lu
  fullname: Lu, Juming
– sequence: 19
  givenname: Jingtao
  surname: Dou
  fullname: Dou, Jingtao
– sequence: 20
  givenname: Nan
  surname: Jin
  fullname: Jin, Nan
– sequence: 21
  givenname: Jing
  surname: Li
  fullname: Li, Jing
– sequence: 22
  givenname: Shuyu
  surname: Wang
  fullname: Wang, Shuyu
– sequence: 23
  givenname: Baojing
  surname: Zhang
  fullname: Zhang, Baojing
– sequence: 24
  givenname: Liguang
  surname: Dong
  fullname: Dong, Liguang
– sequence: 25
  givenname: Jianping
  surname: Weng
  fullname: Weng, Jianping
– sequence: 26
  givenname: Longyi
  surname: Zeng
  fullname: Zeng, Longyi
– sequence: 27
  givenname: Panwei
  surname: Mu
  fullname: Mu, Panwei
– sequence: 28
  givenname: Yanhua
  surname: Zhang
  fullname: Zhang, Yanhua
– sequence: 29
  givenname: Qiuqiong
  surname: Yu
  fullname: Yu, Qiuqiong
– sequence: 30
  givenname: Keyi
  surname: Lin
  fullname: Lin, Keyi
– sequence: 31
  givenname: Yan
  surname: Sun
  fullname: Sun, Yan
– sequence: 32
  givenname: Xiaodong
  surname: Xu
  fullname: Xu, Xiaodong
– sequence: 33
  givenname: Weiping
  surname: Jia
  fullname: Jia, Weiping
– sequence: 34
  givenname: Xuhong
  surname: Hou
  fullname: Hou, Xuhong
– sequence: 35
  givenname: Xiaojing
  surname: Ma
  fullname: Ma, Xiaojing
– sequence: 36
  givenname: Huijuan
  surname: Lu
  fullname: Lu, Huijuan
– sequence: 37
  givenname: Dajing
  surname: Zou
  fullname: Zou, Dajing
– sequence: 38
  givenname: Renming
  surname: Hu
  fullname: Hu, Renming
– sequence: 39
  givenname: Huilin
  surname: Gu
  fullname: Gu, Huilin
– sequence: 40
  givenname: Youhua
  surname: Yao
  fullname: Yao, Youhua
– sequence: 41
  givenname: Weizhen
  surname: Shen
  fullname: Shen, Weizhen
– sequence: 42
  givenname: Junbin
  surname: Huang
  fullname: Huang, Junbin
– sequence: 43
  givenname: Zhijian
  surname: Pan
  fullname: Pan, Zhijian
– sequence: 44
  givenname: Linong
  surname: Ji
  fullname: Ji, Linong
– sequence: 45
  givenname: Xianghai
  surname: Zhou
  fullname: Zhou, Xianghai
– sequence: 46
  givenname: Xueyao
  surname: Han
  fullname: Han, Xueyao
– sequence: 47
  givenname: Xiuying
  surname: Zhang
  fullname: Zhang, Xiuying
– sequence: 48
  givenname: Yingying
  surname: Luo
  fullname: Luo, Yingying
– sequence: 49
  givenname: Xiuqing
  surname: Sun
  fullname: Sun, Xiuqing
– sequence: 50
  givenname: Dong
  surname: Zhao
  fullname: Zhao, Dong
– sequence: 51
  givenname: Huifang
  surname: Xing
  fullname: Xing, Huifang
– sequence: 52
  givenname: Lei
  surname: Liu
  fullname: Liu, Lei
– sequence: 53
  givenname: Xinquan
  surname: Zhang
  fullname: Zhang, Xinquan
– sequence: 54
  givenname: Zhongyan
  surname: Shan
  fullname: Shan, Zhongyan
– sequence: 55
  givenname: Yaxin
  surname: Lai
  fullname: Lai, Yaxin
– sequence: 56
  givenname: Xiaochun
  surname: Teng
  fullname: Teng, Xiaochun
– sequence: 57
  givenname: Ling
  surname: Shan
  fullname: Shan, Ling
– sequence: 58
  givenname: Jiani
  surname: Wang
  fullname: Wang, Jiani
– sequence: 59
  givenname: Liangfeng
  surname: Shi
  fullname: Shi, Liangfeng
– sequence: 60
  givenname: Sen
  surname: Wang
  fullname: Wang, Sen
– sequence: 61
  givenname: Li
  surname: Lu
  fullname: Lu, Li
– sequence: 62
  givenname: Fengwei
  surname: Jiang
  fullname: Jiang, Fengwei
– sequence: 63
  givenname: Beibei
  surname: Wang
  fullname: Wang, Beibei
– sequence: 64
  givenname: Jie
  surname: Liu
  fullname: Liu, Jie
– sequence: 65
  givenname: Ling
  surname: Hu
  fullname: Hu, Ling
– sequence: 66
  givenname: Yuying
  surname: Hou
  fullname: Hou, Yuying
– sequence: 67
  givenname: Haoming
  surname: Tian
  fullname: Tian, Haoming
– sequence: 68
  givenname: Xingwu
  surname: Ran
  fullname: Ran, Xingwu
– sequence: 69
  givenname: Yan
  surname: Ren
  fullname: Ren, Yan
– sequence: 70
  givenname: Hongling
  surname: Yu
  fullname: Yu, Hongling
– sequence: 71
  givenname: Lisheng
  surname: Cao
  fullname: Cao, Lisheng
– sequence: 72
  givenname: Hualin
  surname: Lu
  fullname: Lu, Hualin
– sequence: 73
  givenname: Xiaohua
  surname: Xie
  fullname: Xie, Xiaohua
– sequence: 74
  givenname: Xilian
  surname: Gao
  fullname: Gao, Xilian
– sequence: 75
  givenname: Zhong
  surname: Li
  fullname: Li, Zhong
– sequence: 76
  givenname: Qiuhe
  surname: Ji
  fullname: Ji, Qiuhe
– sequence: 77
  givenname: Fei
  surname: Chen
  fullname: Chen, Fei
– sequence: 78
  givenname: Yaping
  surname: Zhang
  fullname: Zhang, Yaping
– sequence: 79
  givenname: Dalong
  surname: Zhu
  fullname: Zhu, Dalong
– sequence: 80
  givenname: Yun
  surname: Hu
  fullname: Hu, Yun
– sequence: 81
  givenname: Guoyu
  surname: Tong
  fullname: Tong, Guoyu
– sequence: 82
  givenname: Ning
  surname: Xu
  fullname: Xu, Ning
– sequence: 83
  givenname: Jinluo
  surname: Cheng
  fullname: Cheng, Jinluo
– sequence: 84
  givenname: Junjian
  surname: Chen
  fullname: Chen, Junjian
– sequence: 85
  givenname: Fei
  surname: Wang
  fullname: Wang, Fei
– sequence: 86
  givenname: Jiong
  surname: Pei
  fullname: Pei, Jiong
– sequence: 87
  givenname: Jiapu
  surname: Ge
  fullname: Ge, Jiapu
– sequence: 88
  givenname: Wan
  surname: Yi
  fullname: Yi, Wan
– sequence: 89
  givenname: Rong
  surname: Wang
  fullname: Wang, Rong
– sequence: 90
  givenname: Gang
  surname: Han
  fullname: Han, Gang
– sequence: 91
  givenname: Huijie
  surname: Mu
  fullname: Mu, Huijie
– sequence: 92
  givenname: Maimaiti
  surname: Aireti
  fullname: Aireti, Maimaiti
– sequence: 93
  givenname: Lixiang
  surname: Lin
  fullname: Lin, Lixiang
– sequence: 94
  givenname: Gang
  surname: Chen
  fullname: Chen, Gang
– sequence: 95
  givenname: Jingxin
  surname: Zhao
  fullname: Zhao, Jingxin
– sequence: 96
  givenname: Shuyu
  surname: Yang
  fullname: Yang, Shuyu
– sequence: 97
  givenname: Mingzhu
  surname: Lin
  fullname: Lin, Mingzhu
Copyright 2015 INIST-CNRS
Copyright_xml – notice: 2015 INIST-CNRS
CorporateAuthor China National Diabetes and Metabolic Disorders Study Investigators
CorporateAuthor_xml – name: China National Diabetes and Metabolic Disorders Study Investigators
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/CIRCULATIONAHA.111.065904
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1524-4539
EndPage 2221
ExternalDocumentID 22492668
25884768
10_1161_CIRCULATIONAHA_111_065904
Genre Journal Article
GeographicLocations Asia
China
GroupedDBID ---
.-D
.3C
.XZ
.Z2
01R
0R~
0ZK
18M
1J1
29B
2FS
2WC
354
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
6PF
71W
77Y
7O~
AAAAV
AAAXR
AAEJM
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AARTV
AASOK
AAUEB
AAWTL
AAXQO
AAYXX
ABBUW
ABDIG
ABJNI
ABOCM
ABPMR
ABPXF
ABQRW
ABXVJ
ABZAD
ACCJW
ACDDN
ACDOF
ACEWG
ACGFO
ACGFS
ACILI
ACOAL
ACRKK
ACWDW
ACWRI
ACXNZ
ACZKN
ADBBV
ADCYY
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFCHL
AFDTB
AFEXH
AFFNX
AFNMH
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJJEV
AJNWD
AJNYG
AJZMW
ALKUP
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMNEI
ASPBG
AVWKF
AYCSE
AZFZN
BAWUL
BOYCO
BQLVK
BYPQX
C45
CITATION
CS3
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GX1
H0~
H13
HZ~
IKREB
IKYAY
IN~
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
O9-
OAG
OAH
OBH
OCB
ODMTH
OGEVE
OHH
OHYEH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
PQQKQ
RAH
RLZ
S4R
S4S
T8P
TEORI
TR2
UPT
V2I
VVN
W2D
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
XXN
XYM
YFH
YOC
YSK
YYM
YZZ
ZFV
ZY1
ZZMQN
~H1
.55
.GJ
1CY
41~
AAQKA
AASCR
AASXQ
ABASU
ABVCZ
ABXYN
ABZZY
ACLDA
ACXJB
ADFPA
AEBDS
AFBFQ
AFMBP
AFSOK
AHQVU
AKCTQ
AKULP
ALMTX
AMKUR
AOHHW
AOQMC
BS7
C1A
EEVPB
ERAAH
FEDTE
GNXGY
GQDEL
HLJTE
HVGLF
H~9
IPNFZ
IQODW
J5H
M18
MVM
N4W
NEJ
N~M
OCUKA
ODA
OHT
ORVUJ
P-K
R58
RIG
TSPGW
WHG
X7M
YQJ
YXB
YYP
ZGI
ZXP
ACIJW
ACRZS
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
OJAPA
OLW
RHF
7X8
ADKSD
ID FETCH-LOGICAL-c464t-1c526740b5eaf613bdf36abc46c8d95f20f8185b252d65df1095ced9c05845013
ISSN 0009-7322
1524-4539
IngestDate Mon Sep 08 03:07:10 EDT 2025
Wed Feb 19 01:51:35 EST 2025
Mon Jul 21 09:14:47 EDT 2025
Tue Jul 01 04:11:07 EDT 2025
Thu Apr 24 23:11:45 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 18
Keywords Human
lipids
Prevalence
China
Chinese
Cardiovascular disease
Lipoprotein
cross-sectional studies
lipoproteins
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c464t-1c526740b5eaf613bdf36abc46c8d95f20f8185b252d65df1095ced9c05845013
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.111.065904
PMID 22492668
PQID 1021125029
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_1021125029
pubmed_primary_22492668
pascalfrancis_primary_25884768
crossref_citationtrail_10_1161_CIRCULATIONAHA_111_065904
crossref_primary_10_1161_CIRCULATIONAHA_111_065904
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-05-08
PublicationDateYYYYMMDD 2012-05-08
PublicationDate_xml – month: 05
  year: 2012
  text: 2012-05-08
  day: 08
PublicationDecade 2010
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Circulation (New York, N.Y.)
PublicationTitleAlternate Circulation
PublicationYear 2012
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References Luepker RV (e_1_3_3_11_2) 2004
e_1_3_3_16_2
e_1_3_3_19_2
e_1_3_3_18_2
e_1_3_3_13_2
e_1_3_3_12_2
e_1_3_3_14_2
e_1_3_3_30_2
e_1_3_3_10_2
e_1_3_3_31_2
Wong LD (e_1_3_3_17_2) 2005
Li YH (e_1_3_3_15_2) 2002; 12
e_1_3_3_6_2
e_1_3_3_5_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_28_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_24_2
e_1_3_3_23_2
e_1_3_3_26_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_3_2
e_1_3_3_21_2
References_xml – ident: e_1_3_3_18_2
  doi: 10.1093/ije/18.3_Supplement_1.S159
– ident: e_1_3_3_14_2
  doi: 10.1161/01.CIR.85.3.1083
– ident: e_1_3_3_12_2
– ident: e_1_3_3_26_2
  doi: 10.1016/j.amjcard.2004.07.046
– ident: e_1_3_3_25_2
  doi: 10.1161/01.CIR.0000066320.27195.B4
– ident: e_1_3_3_6_2
  doi: 10.1136/bmj.303.6797.276
– ident: e_1_3_3_22_2
  doi: 10.1001/jama.2009.1672
– volume: 12
  start-page: 118
  year: 2002
  ident: e_1_3_3_15_2
  article-title: Serum cholesterol changes from 1983–1984 to 1993–1994 in the People's Republic of China
  publication-title: Nutr Metab Cardiovasc Dis
– ident: e_1_3_3_16_2
  doi: 10.1161/01.CIR.0000136583.52681.0D
– ident: e_1_3_3_30_2
  doi: 10.1093/ajcn/69.4.632
– ident: e_1_3_3_23_2
  doi: 10.1046/j.1467-789X.2002.00071.x
– ident: e_1_3_3_4_2
  doi: 10.1001/jama.284.3.311
– volume-title: Cardiovascular Survey Methods
  year: 2004
  ident: e_1_3_3_11_2
– ident: e_1_3_3_13_2
  doi: 10.1001/jama.285.19.2486
– ident: e_1_3_3_29_2
  doi: 10.1111/j.1467-789X.2010.00819.x
– ident: e_1_3_3_8_2
  doi: 10.1016/S0140-6736(10)62038-7
– ident: e_1_3_3_28_2
  doi: 10.1161/01.CIR.102.2.179
– ident: e_1_3_3_9_2
  doi: 10.1056/NEJMoa0908292
– volume-title: The 2002 China National Nutrition and Health Survey (1): General Report
  year: 2005
  ident: e_1_3_3_17_2
– ident: e_1_3_3_7_2
  doi: 10.1016/S0140-6736(98)03454-0
– ident: e_1_3_3_20_2
  doi: 10.1093/ije/30.suppl_1.S35
– ident: e_1_3_3_10_2
– ident: e_1_3_3_19_2
  doi: 10.1161/01.CIR.97.10.946
– ident: e_1_3_3_24_2
  doi: 10.1371/journal.pone.0017326
– ident: e_1_3_3_2_2
  doi: 10.1111/j.1753-4887.2009.00160.x
– ident: e_1_3_3_21_2
  doi: 10.1001/jama.294.14.1773
– ident: e_1_3_3_3_2
  doi: 10.1056/NEJMsa050467
– ident: e_1_3_3_31_2
  doi: 10.1161/circulationaha.109.192703
– ident: e_1_3_3_5_2
  doi: 10.1001/jama.282.24.2340
– ident: e_1_3_3_27_2
  doi: 10.1001/jama.289.1.76
SSID ssj0006375
Score 2.4886107
Snippet Because of rapid change in lifestyle risk factors, cardiovascular disease has become the leading cause of death in China. We sought to estimate the national...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 2212
SubjectTerms Adult
Asian Continental Ancestry Group - statistics & numerical data
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cholesterol - blood
Cholesterol, HDL - blood
Cholesterol, LDL - blood
Cross-Sectional Studies
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Female
General and cellular metabolism. Vitamins
Health Knowledge, Attitudes, Practice
Humans
Lipids - blood
Lipoproteins - blood
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Title Serum Lipids and Lipoproteins in Chinese Men and Women
URI https://www.ncbi.nlm.nih.gov/pubmed/22492668
https://www.proquest.com/docview/1021125029
Volume 125
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZbB2UwytZuXXYpLoy9FHe2LCn2YwgbWVn3MBqW7cXoZurRxKFxHtpf36OLL2ENdHsxRrJs0Pfp-BzpXBD6QIjUCkc8VELokAghwzRJZBixItWpJlraDbfz72wyJWczOuvKHdnoklqcytt740r-B1VoA1xNlOw_INu-FBrgHvCFKyAM1wdhDAt9PT-5KpelcqmW4baymRdK5x9uqmPrlT6Za-dzbPMt9PXRcXktfQGv--ry9PYJfvmN5Z96cdP87qB5VnJ3dgM0u72suo7m-d-XvPqzbil4VvqdgOZRv-NgXDdoGDkhqb2UxCQk1GUhasWoC2Bu-JL2pSJ2rtJ_i2tmxPX464_x9JtL_jsZGSF-ak57XVniHozLucUR2ySHLO3-YK1fYdP1GD3BQ9ClTPD3rHP5YcmQ7qJj_-VPW79rMkT7N22oK8-WfAUrp3AlT7bbJFY3uXiO9rxREYwcQ16gR3qxjw5GC15X85vgY2DdfO35yT7aPffeFAeIWf4Ejj8B8CPo8ycoF4HnTwCssf2WPy_R9Mvni_Ek9HU0QkkYqcNYUsyGJBJU8wLUN6GKhHEBnTJVGS1wVBi1TWCKFaOqiEHthhWcyQi0Uwo2wiu0A6zQr1GQRIrw2CSRTBSJhcp0RhUveMbThImhHqC0ma5c-iTzptbJVW6NTRbnm5NuDNDcTfoA4Xbo0mVaecigow1M2pHYBGCDKT1Axw1IOQhOcxrGF7par3JT0x44G-FsgA4det1oj_6brT1v0dNuabxDO_X1Wr8H9bQWR5Zzd_2liDQ
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+lipids+and+lipoproteins+in+Chinese+men+and+women&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Yang%2C+Wenying&rft.au=Xiao%2C+Jianzhong&rft.au=Yang%2C+Zhaojun&rft.au=Ji%2C+Linong&rft.date=2012-05-08&rft.eissn=1524-4539&rft.volume=125&rft.issue=18&rft.spage=2212&rft_id=info:doi/10.1161%2FCIRCULATIONAHA.111.065904&rft_id=info%3Apmid%2F22492668&rft.externalDocID=22492668
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon